Tatsuya Toyama

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy

Joji Kato, Yoshiyuki Kuwabara, Masami Mitani et al. · International Journal of Cancer · 2001 · 330 citations

Surgical Oncology, Esophagus, Esophageal Cancer +13

Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast*

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama et al. · Breast Cancer Research and Treatment · 2005 · 306 citations

Breast Oncology, Oncology, Invasive Carcinoma +9

miR-206 Expression Is Down-regulated in Estrogen Receptor α–Positive Human Breast Cancer

Naoto Kondo, Tatsuya Toyama, Hiroshi Sugiura et al. · Cancer Research · 2008 · 301 citations · Full text

HDAC6 Expression Is Correlated with Better Survival in Breast Cancer

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama et al. · Clinical Cancer Research · 2004 · 294 citations · Full text